95 related articles for article (PubMed ID: 36464759)
21. Treatment of Benign Prostatic Hyperplasia by Natural Drugs.
Csikós E; Horváth A; Ács K; Papp N; Balázs VL; Dolenc MS; Kenda M; Kočevar Glavač N; Nagy M; Protti M; Mercolini L; Horváth G; Farkas Á; On Behalf Of The Oemonom
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885733
[TBL] [Abstract][Full Text] [Related]
22. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
[TBL] [Abstract][Full Text] [Related]
23. Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery.
Batai K; Phung M; Bell R; Lwin A; Hynes KA; Price E; Meiklejohn KM; Bracamonte ER; Funk JT
BMC Urol; 2021 Jun; 21(1):88. PubMed ID: 34112139
[TBL] [Abstract][Full Text] [Related]
24. Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study.
Cormio L; Calò B; Falagario U; Iezzi M; Lamolinara A; Vitaglione P; Silecchia G; Carrieri G; Fogliano V; Iacobelli S; Natali PG; Piantelli M
J Transl Med; 2021 Jan; 19(1):24. PubMed ID: 33407599
[TBL] [Abstract][Full Text] [Related]
25. Effects of lycopene on abdominal fat deposition, serum lipids levels and hepatic lipid metabolism-related enzymes in broiler chickens.
Wan X; Yang Z; Ji H; Li N; Yang Z; Xu L; Yang H; Wang Z
Anim Biosci; 2021 Mar; 34(3):385-392. PubMed ID: 33152222
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.
Lokeshwar SD; Harper BT; Webb E; Jordan A; Dykes TA; Neal DE; Terris MK; Klaassen Z
Transl Androl Urol; 2019 Oct; 8(5):529-539. PubMed ID: 31807429
[TBL] [Abstract][Full Text] [Related]
27. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
28. Benign Prostatic Hyperplasia.
Langan RC
Prim Care; 2019 Jun; 46(2):223-232. PubMed ID: 31030823
[TBL] [Abstract][Full Text] [Related]
29. 2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1
Abdel-Naim AB; Neamatallah T; Eid BG; Esmat A; Alamoudi AJ; Abd El-Aziz GS; Ashour OM
Oxid Med Cell Longev; 2018; 2018():4389484. PubMed ID: 30154949
[TBL] [Abstract][Full Text] [Related]
30. Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats.
Shoieb SM; Esmat A; Khalifa AE; Abdel-Naim AB
Food Chem Toxicol; 2018 Jan; 111():650-659. PubMed ID: 29247772
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress and prostatic diseases.
Roumeguère T; Sfeir J; El Rassy E; Albisinni S; Van Antwerpen P; Boudjeltia KZ; Farès N; Kattan J; Aoun F
Mol Clin Oncol; 2017 Nov; 7(5):723-728. PubMed ID: 29181163
[TBL] [Abstract][Full Text] [Related]
32. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of lipidic extracts of saladette tomato pomace and Serenoa repens on prostate and bladder health in obese male Wistar rats.
Espinosa-Juárez JV; Colado-Velázquez JI; Mailloux-Salinas P; Medina-Contreras J; Correa-López PV; Gómez-Viquez NL; Meza-Cuenca F; Huang F; Bravo G
J Sci Food Agric; 2017 Oct; 97(13):4451-4458. PubMed ID: 28276068
[TBL] [Abstract][Full Text] [Related]
34. Hypothesis on
Governa P; Giachetti D; Biagi M; Manetti F; De Vico L
PeerJ; 2016; 4():e2698. PubMed ID: 27904805
[TBL] [Abstract][Full Text] [Related]
35. Association between components of metabolic syndrome and prostatic enlargement: An Indian perspective.
Nandy PR; Saha S
Med J Armed Forces India; 2016 Oct; 72(4):350-355. PubMed ID: 27843182
[TBL] [Abstract][Full Text] [Related]
36. Benign prostatic hyperplasia.
Chughtai B; Forde JC; Thomas DD; Laor L; Hossack T; Woo HH; Te AE; Kaplan SA
Nat Rev Dis Primers; 2016 May; 2():16031. PubMed ID: 27147135
[TBL] [Abstract][Full Text] [Related]
37. Growth, immune, antioxidant, and bone responses of heat stress-exposed broilers fed diets supplemented with tomato pomace.
Hosseini-Vashan SJ; Golian A; Yaghobfar A
Int J Biometeorol; 2016 Aug; 60(8):1183-92. PubMed ID: 26589827
[TBL] [Abstract][Full Text] [Related]
38. Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes.
Chen Z; Miao L; Gao X; Wang G; Xu Y
Int J Clin Exp Med; 2015; 8(7):11289-94. PubMed ID: 26379937
[TBL] [Abstract][Full Text] [Related]
39. What do we know about phytotherapy of benign prostatic hyperplasia?
Allkanjari O; Vitalone A
Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
[TBL] [Abstract][Full Text] [Related]
40. Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF.
Silva SA; Gobbo MG; Pinto-Fochi ME; Rafacho A; Taboga SR; Almeida EA; Góes RM; Ribeiro DL
Int J Exp Pathol; 2015 Feb; 96(1):21-30. PubMed ID: 25529509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
